Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated nasal carbon dioxide as a treatment for seasonal allergic rhinitis and has completed. The study was sponsored by Capnia, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Nasal carbon dioxide (carbon dioxide)

Snippet

Sponsor: Capnia, Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED